Premier Biomedical Competitors and Similar CompaniesClear all

Premier Biomedical's competitors and similar companies include Chiesi Group and UCB.
Premier Biomedical
Premier Biomedical
Premier Biomedical, a research-based firm, develops medical products for Alzheimer's disease, traumatic brain injury, and more.
Chiesi Group
Chiesi Group
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date
Founding Date
2010
Founding Date
1935
Founding Date
1928
Type
Type
Public
Type
Subsidiary
Type
Public
Tags
Locations
Locations
Jackson Center, US HQ
Locations
Parma, IT HQ
Melbourne, AU
Wien, AT
Machelen, BE
Santana De Parnaíba, BR
São Paulo, BR
Sofia, BG
see more
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Employees
Employees
2
Employees
5,8541% increase
Employees
9,052
Valuation ($)
Valuation ($)
1 m
Valuation ($)
N/A
Valuation ($)
34.3 b

Financial

Revenue (est.)
Revenue (est.)
$14.3k (FY, 2019)
Revenue (est.)
€2.4b (Y, 2021)
Revenue (est.)
€7.4b (FY, 2025)
Cost of goods
Cost of goods
$12.9k (FY, 2019)
Cost of goods
N/A
Cost of goods
€1.4b (FY, 2025)
Gross profit
Gross profit
$1.4k (FY, 2019)
Gross profit
N/A
Gross profit
€7.2b (FY, 2025)
Net income
Net income
($374.5k) (FY, 2019)
Net income
N/A
Net income
€1.6b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Chiesi Group
HQ
Parma, IT

Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.

View company
UCB
HQ
Brussels, BE
Employees
9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company